Baby formula suits : Activist investor group Eminence Capital has built a stake of at least 0.5% in Reckitt Benckiser, according to the Financial Times. Eminence's reported position follows Reckitt's selloff to an all-time low in March on concerns about baby formula litigation. Abbott makes a competing baby formula and faces similar lawsuits, alleging the companies failed to warn about the risks of their products. ABT YTD mountain Abbott YTD Abbott's next baby formula event is a state trial in St. Louis that begins in July. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .

---

Persons: Jim Cramer, Eminence's, Reckitt's, Abbott, we've, Reckitt, ABT, YTD Abbott's, Louis, we're, We're, Jim Cramer's, Jim Organizations: CNBC, Nvidia, Blackwell, Eminence, Financial Times, Abbott Labs, TJX, Target, Devices, Jim Cramer's Charitable Locations: Reckitt Benckiser, Illinois, Reckitt, St, Maxx, Williams, Sonoma